10/24/2025
📢 We’re pleased to share that, as part of a planned leadership transition originally announced in April 2025, Payman Khales has assumed the role of President & CEO of Integer and joined our Board of Directors.
He succeeds Joe Dziedzic, who is retiring after eight years of distinguished service as Integer President and CEO and will continue to serve as an advisor through March 31, 2026, to support a smooth transition.
Payman joined Integer in 2018 as President of the Cardio & Vascular business, where he led a successful market- and customer-focused strategy, doubling sales in seven years and driving above-market growth, while further improving service levels and profitability. Most recently, as Chief Operating Officer, he oversaw both of Integer’s business units and its global operations, further strengthening Integer’s reputation as a strategic partner to medical device companies and OEMs worldwide.
“It is a privilege to step into the role of CEO at Integer,” said Payman. “I am energized by the opportunities ahead as we continue to advance our strategy. Together with our talented associates, we will create value by innovating, collaborating with our customers, and delivering life-changing medical technologies to patients around the world. I am grateful to Joe for his mentorship and support, and I look forward to leading Integer.”
Read more: https://www.integer.net/news-and-events/news-details/2025/Payman-Khales-Assumes-Role-as-Integer-President-and-CEO/default.aspx